Which questions remain unanswered following the successful development of sorafenib in hepatocellular carcinoma?
Year: 2008
Type: article
DOI: 10.1038/ncponc1299
Authors: Keith T Flaherty, Weijing Sun
Institutions: Abramson Cancer Center, University of Pennsylvania
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1989544495
